NCT03451370 2026-04-15
COBRA
Istituto Oncologico Veneto IRCCS
Active not recruiting
Clinical Trials
41 trialsNCT06117891 2026-04-15
REFINE-IO
Bayer
Recruiting
NCT07527832 2026-04-14
An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.
Pfizer
Not yet recruiting
NCT02394834 2026-04-13
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
Takeda
Active not recruiting
NCT04862949 2025-12-12
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
Completed
NCT05839951 2025-11-12
STAR-T
Bayer
Completed
NCT05197504 2025-09-05
HCC
CHA University
Completed
NCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
NCT06858956 2025-03-05
Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT06849362 2025-02-27
Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer
Central South University
Enrolling by invitation
NCT06682247 2024-11-12
A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer
Sun Yat-sen University
Not yet recruiting
NCT05717738 2024-06-13
CCGLC-008
Tongji Hospital
Recruiting
NCT06447727 2024-06-07
Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM
Zhongda Hospital
Recruiting
NCT05173298 2024-02-07
HCC
CHA University
Unknown
NCT06199297 2024-01-26
Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma
Sun Yat-sen University
Completed
NCT06031376 2023-09-11
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
Hunan Cancer Hospital
Completed
NCT05354674 2023-07-13
Multimodal Deep Learning Signature for Evaluation of Response to Bevacizumab in Patient With Colorectal Cancer Liver Metastasis
Fudan University
Not yet recruiting
NCT05869097 2023-05-22
Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer
Hunan Cancer Hospital
Completed
NCT01775644 2021-12-02
An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)
Hoffmann-La Roche
Completed
NCT04831528 2021-04-05
Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study
Fudan University
Not yet recruiting
NCT04788381 2021-03-09
The Effects of Preoperative Bevacizumab on Perioperative Complications
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT04213222 2020-08-11
ROBOT
Peking University People's Hospital
Unknown
NCT04397601 2020-05-21
ARBITRATION
National Cancer Institute, Naples
Unknown
NCT03923036 2019-04-22
AVOCETTE
University Hospital, Caen
Unknown
NCT02305615 2018-08-23
AVACONT
Hoffmann-La Roche
Completed
NCT01712347 2018-07-31
An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer
Hoffmann-La Roche
Completed
NCT01506167 2018-05-14
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)
Hoffmann-La Roche
Completed
NCT02831842 2018-01-26
A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
Hoffmann-La Roche
Completed
NCT02623621 2017-12-07
CIRCUS
Azienda Ospedaliero, Universitaria Pisana
Completed
NCT01343901 2017-04-25
PICASSO
Hoffmann-La Roche
Completed
NCT01399190 2016-09-28
An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer
Hoffmann-La Roche
Completed
NCT02842294 2016-07-22
COBEQOL
Centre Hospitalier Universitaire de Besancon
Unknown
NCT02612077 2016-03-11
CONCERT
Hoffmann-La Roche
Completed
NCT01089413 2015-12-16
Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)
Hoffmann-La Roche
Completed
NCT01860144 2015-05-19
An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer
Peking University
Unknown
NCT01507740 2015-04-29
Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
Medical University Innsbruck
Terminated
NCT01912443 2014-04-28
Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer
Sun Yat-sen University
Unknown
NCT01533740 2014-02-04
Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients
University of Rome Tor Vergata
Completed
NCT00661154 2012-08-10
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
Stanford University
Completed
NCT01311050 2011-12-13
A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
King Faisal Specialist Hospital & Research Center
Unknown
NCT01437618 2011-09-21
First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana
Completed